StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.95−0.09 (-4.41%)

Close on Nov 18, 2026Market cap $7.90MP/E 0.0Yield –

Kyntra Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kyntra Bio's market cap was $14.90M on Nov 11, 2026, against $35.60M a year earlier. Over the last 5 years it ranged from $14.90M to $2.22B, with a median of $54.32M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$14.90M-58.0%
2025Dec 31, 2025$35.52M-33.4%
2024Dec 31, 2024$53.36M-38.8%
2023Dec 29, 2023$87.16M-94.2%
2022Dec 30, 2022$1.50B+15.1%
2021Dec 31, 2021$1.31B-61.2%
2020Dec 31, 2020$3.37B-9.9%
2019Dec 31, 2019$3.74B-4.7%
2018Dec 31, 2018$3.93B+1.3%
2017Dec 29, 2017$3.88B+187.3%
2016Dec 30, 2016$1.35B-27.7%
2015Dec 31, 2015$1.87B+417.6%
2014Dec 31, 2014$360.51M–

More Kyntra Bio figures

See a number that looks wrong?